| 引用本文： |
-
王翔,陈国君,洪毅,等.非血栓性髂静脉压迫性病变的血管腔内治疗[J].同济大学学报（医学版）,2017,38(5):58-62. [点击复制]
- WANG Xiang,CHEN Guo-jun,HONG Yi,et al.Endovascular treatment for nonthrombotic iliac vein compression lesions[J].同济大学学报（医学版）,2017,38(5):58-62. [点击复制]
|
|
| 摘要: |
| 目的 回顾性分析单中心腔内治疗非血栓性髂静脉压迫病变（nonthrombotic iliac vein compression lesion，NIVCL）的可行性、有效性及安全性。方法收集2011年2月至2015年6月收治3423例下肢静脉功能不全，其中NIVCL 107例，腔内治疗89例。在腔内治疗的89例中，男48例，女41例，年龄30～73岁，平均（55.9±10.1）岁；左下肢68例，右下肢17例，双下肢4例。手术均采用经患肢股静脉穿刺行髂静脉受压段球囊扩张联合支架植入术，对其中83例合并浅静脉曲张者行大隐静脉高位结扎剥脱术。结果手术成功率100%；术后随访14～48个月，平均15.7个月，支架一期通畅率100%。随访期间，患肢肿胀缓解率89.0%（73/82），溃疡治愈率94.1%（16/17），疼痛缓解率82.6%（19/23）。1例术后1年出现浅静脉曲张复发，再次行硬化剂治疗后静脉曲张消失；另1例术后3月出现血栓性浅静脉炎，予抗凝、抗感染治疗后痊愈。无深静脉血栓形成及介入治疗相关并发症。结论血管腔内治疗NIVCL安全有效，在疾病进展至血栓形成前早期诊治NIVCL是切实可行的。 |
| 关键词: 血管腔内治疗 支架 髂静脉受压综合征 血管成形术 May-Thurner综合征 |
| DOI：10.16118/j.1008-0392.2017.05.012 |
| 投稿时间：2017-02-06 |
| 基金项目: |
|
| Endovascular treatment for nonthrombotic iliac vein compression lesions |
| WANG Xiang,CHEN Guo-jun,HONG Yi,ZHOU Bin,GE Jin,LI Qin-chuan |
| (Dept. of Vascular Surgery, East Hospital, Tongji University, Shanghai 200120, China) |
| Abstract: |
| Objective To evaluate the feasibility, efficacy and safety of endovascular treatment for nonthrombotic iliac vein compression lesions (NIVCL). MethodsClinical data of 89 patients with NIVCL receiving endovascular treatment from Feb 2011 to Jun 2015 were retrospectively analyzed. Among 89 cases, there were 48 males and 41 female with mean of 55.9 (3073) year. The lesions were located in the left lower extremity in 68 cases, in the right side in 17 cases and in both sides in 4 cases. All patients underwent angioplasty and the venous self-expanding stents were implanted. Eighty cases with severe varicose veins were treated with great saphenous vein high ligation and stripping afterwards. ResultsThe success rate of operation was 100% and the primary patency rate of stents was 100%. The mean follow-up time was 15.7 (1448) months. The relief rate of limb edema was 89.0% (73/82), the healing rate of active ulcers was 94.1% (16/17), and the pain relief rate 82.6% (19/23). The varicose veins recrudesced in one case 1 year after intervention, and were treated by sclerotherapy. Superficial thrombophlebitis occurred in one case 3 months after intervention, and was treated by anticoagulation and antibiotics. No deep venous thrombosis（DVT）or intervention-related complications were observed after treatments. ConclusionEndovascular treatment is a safe, feasible and effective therapy for NIVCL before the disease advances to deep venous thrombosis. |
| Key words: endovascular therapy stent iliac vein compression syndrome angioplasty May-Thurner syndrome |
